Jingjing Chen

Here below are the publications (1) participated by Jingjing Chen along with Rocco D’Antuono (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

The Journal of Clinical Investigation, https://www.jci.org/articles/view/131133

Facts & figures

Jingjing Chen has coordinated or participated in 1 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 0 elements tag cloud:

[not enough tags to create a tag cloud]

Jingjing Chen has coordinated or participated in 1 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 1 scientific journals:

The Journal of Clinical Investigation (1)

Jingjing Chen has coordinated or participated in 1 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 15 co-authors being active in Ticino:

Andrea Alimonti (1) Abdullah Alajati (1) Simone Mosole (1) Martina Troiani (1) Marco Losa (1) Laura Pellegrini (1) Jean Philippe Theurillat (1) Gaston De Bernardis (1) Arianna Calcinotto (1) Ajinkya Revandkar (1) Rocco D’Antuono (1) Mariantonietta D’Ambrosio (1) Marco Bolis (1) Ilaria Guccini (1) Emiliano Pasquini (1)

Jingjing Chen has coordinated or participated in 1 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 4 most frequently used terms (excluding 8 not relevant terms) are here listed:

J.C. WORD CLOUD cdcp (1) overexpression (1) prostate (1) cancer (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 8 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Jingjing Chen has participated - as a whole - in 1 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Rocco D’Antuono

1) CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.

Jingjing Chen has participated - as a whole - in 1 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Rocco D’Antuono